Pfizer (USA)

PARP - Inhibitor Combination Treatments Grant Program in United States

Last update: 1 day ago Last update: Jun 27, 2025

Details

Location:USA
USA
Funding agency:
Contracting authority: Pfizer (USA)
Contracting authority type:Supplier / manufacturer
Status:Open
Budget: USD 850,000
Award ceiling: USD 350,000
Award floor:N/A
Sector:Health, Research
Languages:English
Eligible applicants:Government / Public Bodies, Academic Institutions, Private Sector
Eligible citizenships:USA
USA
Date posted: Jun 27, 2025

Attachments 0

Associated Awards

Description

PARP - Inhibitor Combination Treatments Grant Program in United StatesThe Pfizer is accepting applications for PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer (mPC) Landscape.
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Similar grants
By Locations
Funding agency:
NPO
Status:
open
Location:
Africa, EU 27, Europe Non EU 27, Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, French Guiana, Guatemala, Guyana, Honduras, India, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, USA, Venezuela